• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Beneficiaries of Medicare Advantage run higher risk of readmission compared with traditional Medicare

byCaitlyn HuiandDeepti Shroff
June 26, 2019
in Cardiology, Chronic Disease, Public Health, Pulmonology
Reading Time: 2 mins read
Poor olfaction linked to increased mortality in older adults
Share on FacebookShare on TwitterShare on LinkedIn

1. In this retrospective cohort study, the authors observed that Medicare Advantage beneficiaries have a higher risk of readmission compared to traditional Medicare in with regards to congestive heart failure, pneumonia and acute myocardial infarction.

2. There were higher readmission rates for Medicare Advantage beneficiaries compared to traditional Medicare beneficiaries for hospitals in which both Medicare Advantage and traditional beneficiaries were admitted.

Evidence Rating Level: 2 (Good)

Study Rundown: Hospital readmissions are common and incur significant financial costs to Medicare annually. Therefore, reducing readmission rates is a priority for many aspects of the healthcare system in the United States. Typically, readmission rates are calculated with traditional Medicare beneficiaries only, compared to those that are enrolled in the Medicare Advantage program. The authors of this retrospective cohort study therefore contrasted readmission rates between Medicare Advantage and traditional Medicare patients. Medicare Advantage beneficiaries were found to have a higher risk of readmission compared with traditional Medicare patients. Further, it was found that the Healthcare Effectiveness Data and Information Set (HEDIS) underreported admissions of acute myocardial infarction, congestive heart failure and pneumonia. These underreported admissions often had higher readmission rates. This study had several limitations. Of note, the claims data that was utilized did not include detailed measures of illness severity, social determinants of health and other elements. Further, the authors acknowledged that there were some potential unobserved differences between the two study populations.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Medicare Advantage: Issues, Insights, and Implications for the Future

RELATED REPORTS

Shorter antibiotic courses non-inferior for inpatient community-acquired pneumonia

One in Six Medicare Beneficiaries Use Telehealth for Essential Care

In-Depth [retrospective cohort study]: The authors of this retrospective cohort study compared 30-day readmission rates after hospitalization for both Medicare Advantage and traditional Medicare patients for three major conditions: acute myocardial infarction (AMI), congestive heart failure (CHF) and pneumonia between the years of 2011 to 2014. They utilized the Medicare Provider Analysis and Review files to complete this data analysis. The Neuhaus-Kalbfleisch method was used to calculate the within-hospital effect of Medicare Advantage compared to traditional Medicare. The authors observed that patients in Medicare Advantage had lower unadjusted readmission rates compared to those in traditional Medicare for all 3 conditions (16.6% vs. 17.1% for AMI, 21.4% vs. 21.75% for CHF, and 16.3% vs. 16.4% for pneumonia). When risk readjustment was applied, the readmission rates were found to be higher for patients in Medicare Advantage for each measurement. Further, readmission rates were higher for those enrolled in Medicare Advantage in 1098 of 2138 hospitals (51%) after AMI, 1721 of 3373 hospitals (51%) after CHF and 1920 of 3720 hospitals (52%) after pneumonia.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute myocardial infarctioncongestive heart failuremedicareMedicare Advantagepneumoniareadmissions
Previous Post

Adolescent connectedness associated with lower emotional distress and risk behaviors in adulthood

Next Post

#VisualAbstract: Incidence of Herpes Zoster Among Children: 2003–2014

RelatedReports

Prescription of antibiotics for acute respiratory infections increasing
Infectious Disease

Shorter antibiotic courses non-inferior for inpatient community-acquired pneumonia

April 13, 2026
2 Minute Medicine Rewind October 21, 2019
Public Health

One in Six Medicare Beneficiaries Use Telehealth for Essential Care

February 16, 2026
Pulmonary MRI with ultrashort echo time is comparable to pulmonary CT
Chronic Disease

Adjunct corticosteroids likely reduce short-term mortality in severe non-COVID-19 pneumonia

December 1, 2025
PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study
Cardiology

A novel score is effective at identifying non-ST-segment elevation acute coronary syndrome patients with totally occluded infarct-related artery

January 13, 2026
Next Post
#VisualAbstract: Incidence of Herpes Zoster Among Children: 2003–2014

#VisualAbstract: Incidence of Herpes Zoster Among Children: 2003–2014

Meeting families, demographic information affect child abuse work-up

Social robots increase joy, decrease sadness in hospitalized pediatric patients

Poor olfaction linked to increased mortality in older adults

Quick Take: Suicide in older adults living in or transitioning to residential long-term care, 2003 to 2015

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
  • Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.